Yousif Matloub

Summary

Affiliation: University Hospitals Case Medical Center
Country: USA

Publications

  1. ncbi Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group
    Yousif Matloub
    Division of Hematology Oncology, Rainbow Babies and Children s Hospital, Case Western Reserve University, Cleveland, OH 44106, USA
    Blood 118:243-51. 2011
  2. ncbi Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial
    Linda C Stork
    Division of Hematology Oncology, Doernbecher Children s Hospital Oregon Health and Science University, Portland, OR 97239, USA
    Blood 115:2740-8. 2010

Collaborators

Detail Information

Publications2

  1. ncbi Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group
    Yousif Matloub
    Division of Hematology Oncology, Rainbow Babies and Children s Hospital, Case Western Reserve University, Cleveland, OH 44106, USA
    Blood 118:243-51. 2011
    ..71, P = .12). No advantage was found for a second DI; however, replacement of PO MTX, PO mercaptopurine, vincristine, and dexamethasone during IM with vincristine and escalating IV MTX improved EFS...
  2. ncbi Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial
    Linda C Stork
    Division of Hematology Oncology, Doernbecher Children s Hospital Oregon Health and Science University, Portland, OR 97239, USA
    Blood 115:2740-8. 2010
    ..65, P = .002). The toxicities of TG preclude its protracted use as given in this study. This study is registered at http://clinicaltrials.gov as NCT00002744...